Table 1.
Patient and tumor characteristics of 889 Ashkenazi Jewish and 920 non-Ashkenazi sporadic prostate cancer patients treated at Memorial Sloan Kettering-Cancer Center
| Variable | Non-Ashkenazi (%) | Ashkenazi (%) |
|---|---|---|
| Median age on diagnosis | 64 | 68 |
| Race | ||
| White | 93.7 | - |
| Asian | 2.8 | - |
| Black | 1.0 | - |
| Other | 2.5 | - |
| PSA | ||
| <10 | 63.9 | 69.1 |
| 10–20 | 19.0 | 18.6 |
| >20 | 17.1 | 12.3 |
| Gleason Score | ||
| <=6 | 35.3 | 38.4 |
| 7 | 42.1 | 38.7 |
| 8–10 | 22.6 | 22.9 |
| T stage | ||
| T1 | 44.4 | 45.7 |
| T2 | 38.4 | 38.0 |
| T3 | 17.2 | 16.3 |
| Median follow up (Months) | 105 | 108 |
| Death due to prostate cancer | 10.3 | 13.5 |